Real World Evidence on Second-Line Palliative Chemotherapy in Advanced Pancreatic Cancer
Background: The outcome and tolerability of palliative second line chemotherapy for advanced pancreatic cancer (APC) in real life patients are largely unknown. Prognostic parameters for risk stratification and treatment guidance are lacking.Materials and Methods: A population based multicenter retro...
Main Authors: | Emma Gränsmark, Nellie Bågenholm Bylin, Hakon Blomstrand, Mats Fredrikson, Elisabeth Åvall-Lundqvist, Nils O. Elander |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01176/full |
Similar Items
-
Real-World Evidence on Palliative Gemcitabine and Oxaliplatin (GemOx) Combination Chemotherapy in Advanced Biliary Tract Cancer
by: Hanna Lagenfelt, et al.
Published: (2021-07-01) -
Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
by: Hakon Blomstrand, et al.
Published: (2019-01-01) -
Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites
by: Wintzell My, et al.
Published: (2012-08-01) -
Vital Signs in Palliative Care: A Scoping Review
by: Jenny Power, et al.
Published: (2023-09-01) -
Appetite and its association with mortality in patients with advanced cancer – a Post-hoc Analysis from the Palliative D-study
by: Charlotte Goodrose-Flores, et al.
Published: (2023-10-01)